Trials / Completed
CompletedNCT04954911
Clinical Performance of the Globe® Mapping and Ablation System for the Treatment of Atrial Fibrillation
Prospective, Multi-centre, Observational Registry to Evaluate the Clinical Performance of the Globe® Mapping and Ablation System for the Treatment of Atrial Fibrillation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6 (actual)
- Sponsor
- Kardium Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational, multicentre, prospective, post-market product registry for participants with AF for whom ablation by the commercially available Globe Mapping and Ablation System was indicated before enrolment into the registry. The aim of the registry is to confirm the clinical performance and safety of the Globe Mapping and Ablation System in a real-life setting.
Conditions
Timeline
- Start date
- 2021-11-02
- Primary completion
- 2023-05-23
- Completion
- 2023-05-23
- First posted
- 2021-07-08
- Last updated
- 2023-09-18
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT04954911. Inclusion in this directory is not an endorsement.